文献速递外周血管介入腹部DSA

经导管动脉栓塞治疗胰背动脉出血的安全性与疗效

Safety and efficacy of transarterial embolisation for treatment of dorsal pancreatic artery haemorrhage.
PubMed 文献 · Clin Radiol · 2020-12-14

回顾性分析3家三级医疗中心2001年1月至2020年1月间19例接受胰背动脉经导管动脉栓塞的患者,技术成功率100%、临床成功率84.2%(16/19),3例临床失败中2例为其他动脉新发发出血、1例术后1天死于肝衰竭进展;1例发生无症状非靶栓塞(右胫后动脉),无严重并发症,结论认为经导管动脉栓塞治疗胰背动脉出血安全有效。

要点

  • 胰背动脉出血的血管造影表现以假性动脉瘤最常见(14/19),其次为对比剂外溢(4/19)和动脉分支突然截断(1/19)。
  • 胰背动脉起源以脾动脉最常见(7/19),其次为腹腔干(4/19)、肝总动脉(4/19)和肠系膜上动脉(4/19)。
  • 技术成功率100%、临床成功率84.2%(16/19),临床失败者需警惕其他动脉新发出血。

关键影像表现/征象

  • 临床表现包括Jackson-Pratt引流管血性引流液(8例)、黑便(7例)、腹痛(4例)和便血(3例)。
  • 血管造影表现包括假性动脉瘤(14例)、对比剂外溢(4例)和动脉分支突然截断(1例)。
  • 胰背动脉起源为脾动脉(7例)、腹腔干(4例)、肝总动脉(4例)和肠系膜上动脉(4例)。

诊断标准与关键数值

  • 技术成功率为100%,临床成功率为84.2%(16/19)。
  • 3例临床失败中2例发现其他动脉新发出血,1例术后1天因肝衰竭进展死亡。
  • 栓塞剂使用NBCA(N-丁基氰基丙烯酸酯;4例)、微弹簧圈(4例)及两者联合(7例)。

临床应用与阅片要点

  • 存在胰背动脉出血相关临床表现(如Jackson-Pratt引流管血性引流液、黑便、腹痛、便血)时,应知晓胰背动脉可作为潜在出血来源。
  • 术中需识别假性动脉瘤、对比剂外溢、动脉分支突然截断等造影征象,并注意胰背动脉起源变异(脾动脉、腹腔干、肝总动脉、肠系膜上动脉)。
  • 1例发生无症状非靶栓塞(右胫后动脉),无严重并发症;临床失败病例中2例为其他动脉新发出血,术后需关注再出血可能。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To evaluate the safety and efficacy of transarterial embolisation (TAE) of dorsal pancreatic artery (DPA) haemorrhage.

MATERIALS AND METHODS: Nineteen consecutive patients (M:F = 16:3, mean age 59.6 years) who underwent TAE of DPA in three tertiary medical centres between January 2001 to January 2020 were reviewed retrospectively. Angiographic features and the technical and clinical outcomes of TAE were analysed.

RESULTS: The clinical presentations were a bloody drain from the Jackson-Pratt drainage tube (n=8), melaena (n=7), abdominal pain (n=4), and haematochezia (n=3). Angiographic findings included pseudoaneurysm (n=14), contrast media extravasation (n=4), or abrupt cut-off of the arterial branch (n=1). The NBCA (N-butyl-cyanoacrylate; n=4), microcoils (n=4), and a combination of these agents (n=7) were used as embolic agents. The most common origin of the DPA in the present study cohort was the splenic artery (n=7), followed by the coeliac trunk (n=4), common hepatic artery (n=4), and superior mesenteric artery (n=4). Technical and clinical success rates were 100% and 84.2% (16/19), respectively. Of the three clinically unsuccessful cases, two patients were revealed to have newly developed bleeding from another artery. The other patient expired 1 day after the TAE procedure due to a progression of hepatic failure. In one patient, an asymptomatic non-target embolisation occurred in the right posterior tibial artery as a procedure-related complication. No major complications were observed.

CONCLUSION: TAE is safe and effective for the management of bleeding from the DPA. It is important to be aware of the DPA as a potential bleeding source, including the relevant clinical characteristics.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Alhazemi AA, Park S, Shin JH, et al. Safety and efficacy of transarterial embolisation for treatment of dorsal pancreatic artery haemorrhage. Clin Radiol. 2020. PMID: 33334554. doi:10.1016/j.crad.2020.11.111

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。